Walleye Capital’s NKGen Biotech, Inc. Common Stock NKGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-83,919
| Closed | -$867K | – | 3102 |
|
|
2023
Q2 | $867K | Buy |
83,919
+20,064
| +31% | +$207K | ﹤0.01% | 794 |
|
|
2023
Q1 | $647K | Hold |
63,855
| – | – | 0.01% | 897 |
|
|
2022
Q4 | $635K | Buy |
63,855
+19,406
| +44% | +$193K | 0.01% | 907 |
|
|
2022
Q3 | $433K | Hold |
44,449
| – | – | 0.01% | 1116 |
|
|
2022
Q2 | $432K | Hold |
44,449
| – | – | 0.01% | 1096 |
|
|
2022
Q1 | $431K | Hold |
44,449
| – | – | 0.01% | 1053 |
|
|
2021
Q4 | $431K | Sell |
44,449
-7,948
| -15% | -$77.1K | 0.01% | 1047 |
|
|
2021
Q3 | $508 | Buy |
+52,397
| New | +$508 | 0.01% | 758 |
|